A complete listing of currently available online programs is provided below. To view course materials click an available viewing format provided with each listing (PDF, HTML, Interactive). To access online exams and claim credit you must be registered and logged in. To add courses to your "MyAR Archives" user account select the "Add To Cart" button provided with each course title and follow the prompts.
* Gadopiclenol Injection | Considerations for Use in Breast MRI
|
Released:
December 9, 2024
•Expires:
December 31, 2027
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Margarita L. Zuley, MD, FACR
|
While gadolinium-based contrast agents (GBCAs) are essential to performing breast MR imaging, guidance from the US Food and Drug Administration (FDA) and the American College of Radiology (ACR) includes the recommendation of limiting a patient's gadolinium exposure. Gadopiclenol injection, a macrocyclic, high-relaxivity GBCA can address this recommendation by providing high-quality images with half the gadolinium dose as compared to other conventional GBCAs.
This educational program features Dr. Margarita Zuley’s clinical expertise and practice experience. Through case study examples she will share the indications for abbreviated breast MRI and the clinical rationale for implementing optimal imaging protocols using a lower gadolinium dose and clinical examples of the management of MRI detected findings.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the clinical benefits of abbreviated breast MRI for patients with dense breast and/or high-risk factors.
-
Implement lower gadolinium dosing protocols for patients who may experience repeat breast MRI scans.
-
Understand the clinical paradigms and indications for breast MRI as it relates to other imaging modalities.
This program is made possible through an unrestricted educational grant from Bracco Diagnostics Inc.
|
|
|
|
* Advanced MRI Safety Training For Healthcare Professionals (4th Edition): Level 2 MR Personnel
|
Released:
April 22, 2020
•Expires:
March 31, 2025
|
CE credits:
3.0
• Cost:
$50.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
This program reviews fundamental MRI safety information and meets the annual training recommendations from the American College of Radiology. Importantly, MRI facilities must now comply with the revised requirements for diagnostic imaging from The Joint Commission and document that MRI technologists participate in ongoing education that includes annual training on safe MRI practices in the MRI environment. Notably, Advanced MRI Safety Training for Healthcare Professionals, Level 2 MR Personnel covers each MRI safety topic specified by The Joint Commission, as well as many additional subjects that will expand the knowledge-base of healthcare professionals involved with MRI technology.
With 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Advanced MRI Safety Training for Healthcare Professionals (4th Edition), Level 2 MR Personnel is a 2 hour and 45 minute program that is divided into three different sections.
Educational Objectives
-
Understand the safety issues related to MRI.
-
Describe the bioeffects associated with the static magnetic field, time-varying magnetic fields, and radiofrequency fields.
-
Present guidelines that prevent projectile-related accidents.
-
Describe polices that avoid issues related to acoustic noise.
-
Review procedures that prevent burns associated with MRI.
-
Explain and demonstrate appropriate pre-MRI screening procedures.
-
Identify techniques to manage patients with claustrophobia, anxiety, or emotional distress.
-
Describe guidelines to handle medical emergencies in the MRI setting.
-
Understand the safety considerations for gadolinium-based contrast agents.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
* Basic MRI Safety Training (4th Edition): Level 1 MR Personnel
|
Released:
May 3, 2023
•Expires:
May 31, 2026
|
CE credits:
1.0
• Cost:
$30.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
Individuals entering the magnetic resonance imaging (MRI) environment, whether on a regular or infrequent basis, must be properly trained to ensure their safety, the protection of patients, and the security of other facility staff members. This program, Basic MRI Safety Training, Level 1 MR Personnel accomplishes the initial training that is necessary to ensure safety in the unique setting associated with the MRI system. It includes information pertaining to MRI technology, describes common hazards and unique dangers associated with the MRI setting, and presents vital recommendations and guidelines to prevent accidents and injuries. Importantly, this program provides the fundamental MRI safety information for Level I MR Personnel recommended by the American College of Radiology and may be utilized by individuals preparing for safety training as Level 2 MR Personnel.
With more than 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Educational Objectives
-
Appreciate the importance of MRI
-
Identify the hazards associated with MRI
-
Understand the screening process
-
Describe steps to prevent accidents and injuries
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
Clinical Applications of MR Imaging in Stereotactic Localization Radiosurgery Procedures
|
Released:
January 2, 2024
•Expires:
January 31, 2027
|
CE credits:
1.5
• Cost:
$0.00
|
Faculty:
Jenny WU, MD | Glen Stevens, DO, PhD
|
Gadolinium-based contrast agents (GBCAs) are essential for enhancing the quality of MRI scans to make it easier for radiologists to identify pathology. The US Food and Drug Administration (FDA) and the American College of Radiology (ACR) recommend limiting patient exposure to gadolinium where possible.
One technique for reducing this exposure is to use a high relaxivity GBCA that can be administered at a lower dose than a conventional GBCA, without any impact on image quality. GBCA selection for interventional procedures such as radiosurgery is one such example, where the selection of a GBCA can play a role in patient management and outcomes.
In this program, an experienced neuroradiologist and neuro oncologist will present their clinical experiences with the use of stereotactic localization radiosurgery, following the administration of a high relaxivity GBCA. Through case study examples, the clinical impact of contrast selection will be demonstrated. Following the presentation, questions from the audience will be addressed during a live Q&A.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Review the role of stereotactic radiosurgery (SRS) for brain metastases and the role of pre-operative localization MRI exams for stereotactic radiosurgery.
-
Outline the differences between gadopiclenol and other group II gadolinium-based contrast agents.
-
Discuss the use of gadopiclenol in specific case-based scenarios for stereotactic localization exams and its impact on patient management.
This program is made possible through an unrestricted educational grant from Guerbet.
|
|
|
|
Gadopiclenol | Considerations for Use in Pediatric MRI
|
Released:
April 29, 2024
•Expires:
April 30, 2027
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Shreyas Vasanawala, MD, PhD
|
This educational program featuring Dr. Shreyas Vasanawala will cover pediatric MR imaging applications using Gadopiclenol, a recently approved gadolinium-based contrast agent (GBCAs).
Following a brief review of the literature and the currently available GBCAs, Dr. Vasanawala will discuss practice considerations as they relate to MRI contrast media selection and dose administration. Additionally, Dr. Vasanawala will share several case studies demonstrating the clinical value and benefits of Gadopiclenol for patients who may present with complex pathology and/or who may be subject to repeat contrast-enhanced MRI exams over their lifetime.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the properties that distinguish gadopiclenol injection from the other high relaxivity gadolinium-based contrast agents (GBCAs).
-
Employ the FDA-approved indications and clinical applications for gadopiclenol injection in pediatric patients.
-
Apply clinical considerations and dosing options for gadopiclenol administered to vulnerable patient populations who may experience repeat, lifetime dosing of a GBCA.
This program is made possible through an unrestricted educational grant from Bracco Diagnostics Inc.
|
|
|
|
Gadopiclenol Injection | Practical Considerations for Use
|
Released:
October 23, 2023
•Expires:
October 22, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT
|
With the recent FDA approval of gadopiclenol injection, radiologists now have the choice of a macrocyclic gadolinium-based contrast agent (GBCA) with 2 – 3 times higher relaxivity at a lower standard dose as compared to other gadolinium-based contrast agents on the marke
Therefore, and because gadopiclenlol is different than other currently available GBCAs, a review of the clinical benefits of using a higher relaxivity GBCA at a lower administered dose is important. A clear understanding of relaxivity and calculation of the volume to be administered based on dosing considerations, is necessary
In this accredited webinar, Mr. Faulkner will provide insights into the differences of the current FDA-approved GBCAs and how these differences apply to MR imaging. Following the presentation, questions from the audience were addressed during a live Q&A.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Identify the properties that distinguish gadopiclenol injection from the other high relaxivity and conventional gadolinium-based contrast agents (GBCAs).
-
Employ the FDA-approved indications and clinical applications for gadopiclenol injection.
-
Calculate and administer the proper volume dose of gadopiclenol, as compared to other conventional GBCAs.
-
Apply clinical considerations and dosing options for gadopiclenol to vulnerable patient populations who may experience repeat dosing of GBCA.
Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
MRI Safety Considerations for Implants and Devices
|
Released:
February 1, 2023
•Expires:
February 28, 2026
|
CE credits:
1.5
• Cost:
$30.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|
This accredited program provides a comprehensive overview of MRI safety considerations for passive / active implants, and devices.
When considering patient safety during MR imaging, it is critical to assess the patient’s history and have a clear understanding of any passive and or active implants and/or devices. The ACR Manual on MR Safety states that the Radiologist is responsible for the safety of the patient undergoing the MRI Exam. They are also responsible for implementing MR Safety policies and procedures and ensuring that the facilities’ personnel adhere to them at all time. Regarding implants and devices, regular reviews and updates to the MRI safety policy should be completed.
With more than 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present this important MRI Safety information designed for MRI Imaging professionals.
Educational Objectives
-
Name and describe the current labeling terminology for implants & devices.
-
Safely image patients with passive and active, MR Conditional implants and devices.
-
Establish a comprehensive MRI Safety protocol for imaging implants & devices.
Program support provided by Bracco Diagnostics, Inc.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
MRI Safety Considerations For The Radiologist
|
Released:
February 16, 2023
•Expires:
February 28, 2026
|
CE credits:
1.5
• Cost:
$30.00
|
Faculty:
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT | Kristan Harrington, MBA, R.T.(R)(MR), ARRT, MRSO
|
This accredited program provides a comprehensive overview of MRI safety including the radiologist's responsibilities and liabilities, MRI staff education and patient safety. It is designed specifically for practicing radiologists, fellows, residents, and healthcare professionals who oversee MRI services and will provide practical guidance from two respected MRI safety educators who present information on accepted safety standards of care based on the 2020 ACR Manual on MR Safety, the 2021 FDA Guidance Document, and a review of the literature.
Program Considerations: It is critical to have established MRI safety protocols and to have a clear understanding of the basics of MRI Safety. The ACR Manual on MR Safety states that the Radiologist is responsible for the safety of the patient undergoing the MRI Exam. They are also responsible for implementing MR Safety policies and procedures and ensuring that the facilities’ personnel adhere to them at all time. These MRI safety policies should be reviewed and updated annually in order to prevent patient injury.
Educational Objectives
-
Describe the difference between Level 1 & Level 2 MR personnel.
-
Differentiate and identify the ACR-designated Safety Zones.
-
Implement safety considerations for the static magnetic field, time-varying gradient magnetic fields, and radiofrequency fields.
-
Employ procedures and protocols to prevent RF-related burns and methods to manage SAR levels.
-
Manage acute and chronic gadolinium-based contrast agent adverse events.
Program support provided by Bracco Diagnostics, Inc.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|